|
Other Treatment
Citations 121-130 of 726 total displayed.
|
Past content
(since Jan 1999):
|
- Correspondence
Letter by Teerlink Regarding Article, "L-Arginine Supplementation in Peripheral Arterial Disease: No Benefit and Possible Harm"
- Tom Teerlink
Circulation 2008;117:e157, doi:10.1161/CIRCULATIONAHA.107.729830
[Full text]
- Editorials
Regulatory Perspective on Embolic Protection Device Approval for Saphenous Vein Graft Stenting With a Single-Arm Trial Using Risk-Adjusted Prediction Model
- Robert P. Fiorentino, Bram Zuckerman, and Takahiro Uchida
Circulation 2008;117:714-716, doi:10.1161/CIRCULATIONAHA.107.719617
[Full text]
- Interventional Cardiology
Saphenous Vein Graft Stenting and Major Adverse Cardiac Events: A Predictive Model Derived From a Pooled Analysis of 3958 Patients
- Alanna Coolong, Donald S. Baim, Richard E. Kuntz, A. James O’Malley, Sachin Marulkar, Donald E. Cutlip, Jeffrey J. Popma, and Laura Mauri
Circulation 2008;117:790-797; published online before print as doi:10.1161/CIRCULATIONAHA.106.651232
[Abstract]
[Full text]
- Heart Failure
Randomized Double-Blind Trial of Darbepoetin Alfa in Patients With Symptomatic Heart Failure and Anemia
- Jalal K. Ghali, Inder S. Anand, William T. Abraham, Gregg C. Fonarow, Barry Greenberg, Henry Krum, Barry M. Massie, Scott M. Wasserman, Marie-Louise Trotman, Yan Sun, Beat Knusel, Paul Armstrong on behalf of the Study of Anemia in Heart Failure Trial (STAMINA-HeFT) Group
Circulation 2008;117:526-535; published online before print as doi:10.1161/CIRCULATIONAHA.107.698514
[Abstract]
[Full text]
- Articles
Saphenous Vein Graft Stenting and Major Adverse Cardiac Events. A Predictive Model Derived From a Pooled Analysis of 3958 Patients
- Alanna Coolong, Donald S. Baim, Richard E. Kuntz, A. James O’Malley, Sachin Marulkar, Donald E. Cutlip, Jeffrey J. Popma, and Laura Mauri
Circulation published January 22, 2008, doi:10.1161/CIRCULATIONAHA.106.651232
[Abstract]
- Health Services and Outcomes Research
Electronic Alerts Versus On-Demand Decision Support to Improve Dyslipidemia Treatment: A Cluster Randomized Controlled Trial
- Jacobus T. van Wyk, Marc A.M. van Wijk, Miriam C.J.M. Sturkenboom, Mees Mosseveld, Peter W. Moorman, and Johan van der Lei
Circulation 2008;117:371-378; published online before print as doi:10.1161/CIRCULATIONAHA.107.697201
[Abstract]
[Full text]
- New Drugs and Technologies
New Drugs for the Treatment of Diabetes Mellitus: Part I: Thiazolidinediones and Their Evolving Cardiovascular Implications
- Darren K. McGuire and Silvio E. Inzucchi
Circulation 2008;117:440-449, doi:10.1161/CIRCULATIONAHA.107.704080
[Full text]
- Correspondence
Response to Letter Regarding Article, "Randomized Trial of Acupuncture to Lower Blood Pressure"
- Frank A. Flachskampf, Alois Wortmann, Lutz Klinghammer, Werner G. Daniel, Joachim Gallasch, Wolfgang Pflederer, Olaf Gefeller, Annette B. Pfahlberg, Junxue Gan, and Juntong Mao
Circulation 2008;117:e13, doi:10.1161/CIRCULATIONAHA.107.736579
[Full text]
- Editor's Note
Editor’s Note
- Gilbert R. Upchurch, Jr
Circulation 2008;117:130, doi:10.1161/CIRCULATIONAHA.107.188572
[Full text]
- Articles
Randomized Double-Blind Trial of Darbepoetin Alfa in Patients With Symptomatic Heart Failure and Anemia
- Jalal K. Ghali, Inder S. Anand, William T. Abraham, Gregg C. Fonarow, Barry Greenberg, Henry Krum, Barry M. Massie, Scott M. Wasserman, Marie-Louise Trotman, Yan Sun, Beat Knusel, Paul Armstrong on behalf of the Study of Anemia in Heart Failure Trial (STAMINA-HeFT) Group
Circulation published January 14, 2008, doi:10.1161/CIRCULATIONAHA.107.698514
[Abstract]
|
|
